We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Dragonfly Therapeutics

News List

BMS signs $475m licensing deal with Dragonfly Therapeutics pharmaceutical-technology
August 19, 2020
Bristol Myers Squibb (BMS) has signed an agreement for an exclusive worldwide licence to Dragonfly Therapeutics’ interleukin-12 (IL-12) investigational immunotherapy programme.
Merck signs drug development deal with Dragonfly Therapeutics pharmaceutical-technology
March 23, 2020
Merck (MSD) has partnered with Dragonfly Therapeutics for the discovery, development and commercialisation of drug candidates across oncology, infectious disease and immune disorder indications.
Dragonfly Therapeutics announces the expansion of its strategic collaboration with Celgene pharmaphorum
November 26, 2018
Dragonfly Therapeutics, Inc today announced that it has entered into an agreement with Celgene Corporation and its subsidiaries ("Celgene") to research...